This collaboration is a significant steppingstone for the future of how patients will be able to manage their health and connect to pharmaceutical stakeholders.
COLUMBUS, Ohio (PRWEB) July 12, 2022
Today, Redi.Health, provider of health management technology that improves total patient health, is announcing a collaboration with Labcorp, a leading global life sciences company. Through this combined effort, Labcorp Drug Development’s Patient Access Solutions will integrate Redi.Health’s digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.
Labcorp Drug Development’s Patient Access Solutions works on behalf of pharmaceutical and biotechnology companies to deliver advanced technology and personal support solutions for patients and providers. These solutions include programs focused on access and reimbursement patient support programs, in-home nursing and phlebotomy services, patient co-pay and financial assistance, non-commercial specialty pharmacy dispensing, market access consulting, and field-based reimbursement support.
“Redi.Health shares our goal of leveraging technology to improve health and lives, and their platform will help change the way medications are understood and managed by the individuals taking them,” said Lynne Dominick Sager, vice president of Labcorp Drug Development’s Patient Access Solutions. “This innovative approach improves patient adherence and total health management.”
The collaboration with Redi.Health features access to support resources for patients who are receiving services through Labcorp Drug Development’s Patient Access hub programs, and native app features that allows patients to comprehensively manage their total health and connect with their provider(s). In addition, patients have the flexibility to communicate with Labcorp Drug Development and their connected providers via in-app messaging, bi-directional text and email, live chat including video, call scheduling capabilities, and engagement dashboards.
“Labcorp Drug Development is helping individuals manage their health and make more informed decisions. This collaboration is a significant steppingstone for the future of how patients will be able to manage their health and connect to pharmaceutical stakeholders,” said Luke Buchanan, co-founder and CEO of Redi.Health. “By delivering novel access to partnered manufacturers, we’re offering a total health management solution that increases each patient’s ability to participate in their journey—and ultimately, aims to improve their adherence and quality of life.”
Redi.Health combines health management technology and pharmaceutical manufacturer support into one tool. With this single patient interface, consumers now have access to their complete health and can manage all aspects within the Redi.Health platform. For more information about Redi.Health’s ground-breaking approach, visit https://www.redi.health.
Redi.Health was founded with a simple goal: Empower patients to take control of and contribute to their health journey. We believe that when it comes to healthcare, the patient is often forgotten and left to navigate the overwhelming world of healthcare on their own. To fix this problem we developed Redi.Health. Redi puts more simplified tools in the hands of patients than ever before and creates novel pathways of connectivity to the support and resources patients wouldn’t otherwise have access to. It’s simple – we believe in patients and give them the tools to take control of their health.